StonvexLoading…
StonvexStonvexStonvexCore line items from PLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $33.75M | $52.74M | $43.62M | $25.77M |
Operating Income | $21.15M | $-5.50M | $-842.00K | $-2.97M |
Net Income | $18.32M | $-6.60M | $-1.10M | $-3.46M |
EPS (Diluted) | $0.22 | $-0.08 | $-0.01 | $-0.04 |
Total Assets | $102.34M | $82.35M | $82.26M | $78.49M |
Total Liabilities | $35.11M | $34.12M | $29.36M | $28.58M |
Cash & Equivalents | $41.00M | $14.68M | $13.65M | $17.89M |
Free Cash Flow OCF − CapEx | $21.26M | $-13.63M | $-15.26M | $-11.03M |
Shares Outstanding | 83.05M | 80.43M | 78.23M | 77.65M |